BTIG lowered the firm’s price target on Pinstripes (PNST) to $2 from $3 and keeps a Buy rating on the shares. The firm notes that the company ...

BTIG lowered the firm’s price target on Exact Sciences (EXAS) to $65 from $75 but keeps a Buy rating on the shares after its Q4 results and ...

Wall Street is gearing up for another wave of blank check companies from seasoned and first-time sponsors, showing the ...

Taylor Morrison Home (NYSE:TMHC – Get Free Report) had its target price decreased by analysts at JPMorgan Chase & Co. from ...

Investing.com -- BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage ...

BTIG Research decreased their Q1 2025 earnings estimates for shares of Meritage Homes in a report issued on Tuesday, February ...

Oncocyte will host one-on-one meetings with interested investors. Investors attending the conference wishing to schedule a meeting are encouraged to contact BTIG to schedule.

BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...

On Wednesday, BTIG analyst Carl Reichardt Jr. maintained a Neutral rating on shares of NVR Inc . (NYSE:NVR), while slightly lowering earnings per share (EPS) estimates for the upcoming years.

On Monday, BTIG analyst Andrew Harte maintained a Neutral rating on Global Payments Inc. (NYSE:GPN) stock, despite an approximate 11% increase in share value since the company's third-quarter 2024 ...